Serum antibodies to HIV-1 in recombinant vaccinia virus recipients boosted with purified recombinant gp160. NIAID AIDS Vaccine Clinical Trials Network (Q41597581)

From Wikidata

Jump to navigation Jump to search

scientific article published on November 1, 1992

Language	Label	Description	Also known as
English	Serum antibodies to HIV-1 in recombinant vaccinia virus recipients boosted with purified recombinant gp160. NIAID AIDS Vaccine Clinical Trials Network	scientific article published on November 1, 1992

Statements

scholarly article

1 reference

Europe PubMed Central

4 October 2017

Serum antibodies to HIV-1 in recombinant vaccinia virus recipients boosted with purified recombinant gp160. NIAID AIDS Vaccine Clinical Trials Network (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1287035

9 September 2022

object named as

vaccinia virus

1 reference

based on heuristic

inferred from title

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1287035

9 September 2022

author name string

D. C. Montefiori

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1287035

9 September 2022

B. S. Graham

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1287035

9 September 2022

S. Kliks

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1287035

9 September 2022

P. F. Wright

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1287035

9 September 2022

language of work or name

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1287035

9 September 2022

publication date

1 November 1992

1 reference

Europe PubMed Central

4 October 2017

Journal of Clinical Immunology

1 reference

Europe PubMed Central

4 October 2017

12

1 reference

Europe PubMed Central

4 October 2017

6

1 reference

Europe PubMed Central

4 October 2017

429-439

1 reference

Europe PubMed Central

4 October 2017

https://scigraph.springernature.com/pub.10.1007/bf00918855

0 references

Vaccination of vaccinia-naive adults with human immunodeficiency virus type 1 gp160 recombinant vaccinia virus in a blinded, controlled, randomized clinical trial. The AIDS Vaccine Clinical Trials Network

1 reference

https://pubmed.ncbi.nlm.nih.gov/1287035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Induction of CD4+ human cytolytic T cells specific for HIV-infected cells by a gp160 subunit vaccine

1 reference

https://pubmed.ncbi.nlm.nih.gov/1287035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antibody-dependent enhancement of human immunodeficiency virus type 1 infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/1287035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

LAV revisited: origins of the early HIV-1 isolates from Institut Pasteur

1 reference

https://pubmed.ncbi.nlm.nih.gov/1287035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The safety and immunogenicity of a human immunodeficiency virus type 1 (HIV-1) recombinant gp160 candidate vaccine in humans. NIAID AIDS Vaccine Clinical Trials Network

1 reference

https://pubmed.ncbi.nlm.nih.gov/1287035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lymphoproliferative responses to mitogens and HIV-1 envelope glycoprotein among volunteers vaccinated with recombinant gp160

1 reference

https://pubmed.ncbi.nlm.nih.gov/1287035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Salivary antibodies to human immunodeficiency virus type 1 in a phase I AIDS vaccine trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/1287035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neutralization of multiple HIV-1 isolates from a single subject by autologous sequential sera

1 reference

https://pubmed.ncbi.nlm.nih.gov/1287035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Two immunodominant domains of gp41 bind antibodies which enhance human immunodeficiency virus type 1 infection in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/1287035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A human monoclonal antibody against the CD4-binding site of HIV1 gp120 exhibits potent, broadly neutralizing activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/1287035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neutralizing and complement-dependent enhancing antibodies in different stages of HIV infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/1287035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1287035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transient High Levels of Viremia in Patients with Primary Human Immunodeficiency Virus Type 1 Infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/1287035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

IgG subclass response to HIV in relation to antibody-dependent cellular cytotoxicity at different clinical stages

1 reference

https://pubmed.ncbi.nlm.nih.gov/1287035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rapid development of isolate-specific neutralizing antibodies after primary HIV-1 infection and consequent emergence of virus variants which resist neutralization by autologous sera.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1287035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/1287035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human immunodeficiency virus (HIV-1) gp160-specific lymphocyte proliferative responses of mononuclear leukocytes from HIV-1 recombinant gp160 vaccine recipients

1 reference

https://pubmed.ncbi.nlm.nih.gov/1287035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunoassay for the detection and quantitation of infectious human retrovirus, lymphadenopathy-associated virus (LAV).

1 reference

https://pubmed.ncbi.nlm.nih.gov/1287035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of antiviral drugs and neutralizing antibodies to human immunodeficiency virus by a rapid and sensitive microtiter infection assay.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1287035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Conformational epitope on gp120 important in CD4 binding and human immunodeficiency virus type 1 neutralization identified by a human monoclonal antibody

1 reference

https://pubmed.ncbi.nlm.nih.gov/1287035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention of HIV-1 infection in chimpanzees by gpl20 V3 domain-specific monoclonal antibody

1 reference

https://pubmed.ncbi.nlm.nih.gov/1287035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immune enhancement of viral infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/1287035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Protection of macaques against SIV infection by subunit vaccines of SIV envelope glycoprotein gp160.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1287035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safety of and immunological response to a recombinant vaccinia virus vaccine expressing HIV envelope glycoprotein

1 reference

https://pubmed.ncbi.nlm.nih.gov/1287035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Isotypic restriction of the antibody response to human immunodeficiency virus

1 reference

https://pubmed.ncbi.nlm.nih.gov/1287035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Augmentation of human immunodeficiency virus type 1 neutralizing antibody by priming with gp160 recombinant vaccinia and boosting with rgp160 in vaccinia-naive adults. The NIAID AIDS Vaccine Clinical Trials Network

1 reference

https://pubmed.ncbi.nlm.nih.gov/1287035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antibody-enhanced infection by HIV-1 via Fc receptor-mediated entry

1 reference

https://pubmed.ncbi.nlm.nih.gov/1287035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Type C virus particles in a cord T-cell line derived by co-cultivating normal human cord leukocytes and human leukaemic T cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/1287035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of passive immunization in patients with the acquired immunodeficiency syndrome-related complex and acquired immunodeficiency syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/1287035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Type-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides

1 reference

https://pubmed.ncbi.nlm.nih.gov/1287035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characterization of serum antibody responses to recombinant HIV-1 gp160 vaccine by enzyme immunoassay. NIAID AIDS Vaccine Clinical Trials Network

1 reference

https://pubmed.ncbi.nlm.nih.gov/1287035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of human immunodeficiency virus antigen (HIV-Ag) in serum and cerebrospinal fluid during acute and chronic infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/1287035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of AIDS virus envelope gene in recombinant vaccinia viruses

1 reference

https://pubmed.ncbi.nlm.nih.gov/1287035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Optimal conditions for recovery of the human immunodeficiency virus from peripheral blood mononuclear cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/1287035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neutralization of diverse HIV-1 strains by monoclonal antibodies raised against a gp41 synthetic peptide

1 reference

https://pubmed.ncbi.nlm.nih.gov/1287035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neutralizing antibodies against HIV-1 BRU and SF2 isolates generated in mice immunized with recombinant vaccinia virus expressing HIV-1 (BRU) envelope glycoproteins and boosted with homologous gp160.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1287035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An IgG human monoclonal antibody that reacts with HIV-1/GP120, inhibits virus binding to cells, and neutralizes infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/1287035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Markers of HIV infection prior to IgG antibody seropositivity

1 reference

https://pubmed.ncbi.nlm.nih.gov/1287035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Absence of a clinical correlation for complement-mediated, infection-enhancing antibodies in plasma or sera from HIV-1-infected individuals. Multicenter AIDS Cohort Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/1287035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Emergence of viruses resistant to neutralization by V3-specific antibodies in experimental human immunodeficiency virus type 1 IIIB infection of chimpanzees.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1287035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identification of human immunodeficiency virus subtypes with distinct patterns of sensitivity to serum neutralization

1 reference

https://pubmed.ncbi.nlm.nih.gov/1287035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antifusion activity in sera from persons infected with human immunodeficiency virus type 1

1 reference

https://pubmed.ncbi.nlm.nih.gov/1287035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunization of chimpanzees confers protection against challenge with human immunodeficiency virus

1 reference

https://pubmed.ncbi.nlm.nih.gov/1287035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Polymerase chain reaction evidence for human immunodeficiency virus 1 neutralization by passive immunization in patients with AIDS and AIDS-related complex

1 reference

https://pubmed.ncbi.nlm.nih.gov/1287035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

IgG subclass responses to a transmembrane protein (gp41) peptide in HIV infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/1287035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of monoclonal antibodies to HIV-1 by neutralization and serological assays: an international collaboration. Collaborating Investigators.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1287035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum enhancement of human immunodeficiency virus (HIV) infection correlates with disease in HIV-infected individuals

1 reference

https://pubmed.ncbi.nlm.nih.gov/1287035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characterization of the AIDS-associated retrovirus reverse transcriptase and optimal conditions for its detection in virions

1 reference

https://pubmed.ncbi.nlm.nih.gov/1287035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention of HIV infection by passive immunization with HIV immunoglobulin

1 reference

https://pubmed.ncbi.nlm.nih.gov/1287035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein

1 reference

https://pubmed.ncbi.nlm.nih.gov/1287035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neutralization of Divergent HIV-1 Isolates by Conformation-Dependent Human Antibodies to Gp120

1 reference

https://pubmed.ncbi.nlm.nih.gov/1287035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00918855

1 reference

Europe PubMed Central

4 October 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

4 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41597581&oldid=1892460799"